DAL
29
-7
FLR
48
3
TGNA
72
2
KR
63
-2
DVA
65
3
T
66
-3
PH
67
5
TDC
30
2
NUE
37
3
MUR
47
3
R
70
5
VRSK
73
3
CAH
64
3
APD
44
2
FDX
51
14
MO
62
-7
FOXA
67
3
CTSH
56
12
ADT
69
3
KHC
36
-2
DAL
29
-7
FLR
48
3
TGNA
72
2
KR
63
-2
DVA
65
3
T
66
-3
PH
67
5
TDC
30
2
NUE
37
3
MUR
47
3
R
70
5
VRSK
73
3
CAH
64
3
APD
44
2
FDX
51
14
MO
62
-7
FOXA
67
3
CTSH
56
12
ADT
69
3
KHC
36
-2
Financhill
Back

Jones Lang LaSalle 10K Form

Buy
63

JLL
Jones Lang LaSalle

Last Price:
$231.91
Seasonality Move:
0.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive JLL News And Ratings

See the #1 stock for the next 7 days that we like better than JLL

JLL Financial Statistics

Sales & Book Value

Annual Sales: $23.4B
Cash Flow: $868.1M
Price / Cash Flow: 20.23
Annual Sales: $142.81
Price / Book: 1.76

Profitability

EPS (TTM): 11.29000
Net Income (TTM): $546.8M
Gross Margin: $11B
Return on Equity: 8.29%
Return on Assets: 3.33%

Jones Lang LaSalle Earnings Forecast

Key Jones Lang LaSalle Financial Ratios

  • The Gross Profit Margin over the past 26 years for JLL is 57.03%.
  • The Selling, General & Administrative Expenses for JLL have been equal to 46.92% of Gross Profit Margin.
  • The Interest Expense is 10.54% of Operating Income.
  • The Net Earning history of JLL is 2.33% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 19 years.

Jones Lang LaSalle Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Real Estate Management & Development
Sector: Real Estate
Current Symbol: JLL
CUSIP: 48020Q
Website: jll.com

Debt

Debt-to-Equity Ratio: 0.3
Current Ratio: 1.05
Quick Ratio: 0.96

Price-to-Earnings

Trailing P/E Ratio: 22.2
Forward P/E Ratio: 12.73

JLL Technical Analysis vs Fundamental Analysis

Buy
63
Jones Lang LaSalle (JLL) is a Buy

Is Jones Lang LaSalle a Buy or a Sell?

  • Jones Lang LaSalle stock is rated a Buy
    The current Jones Lang LaSalle [JLL] share price is $250.86. The Score for JLL is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.